Obalon Therapeutics, Inc. – NASDAQ:OBLN

Obalon Therapeutics stock price today

$3.05
+2.54
+507.09%
Financial Health
0
1
2
3
4
5
6
7
8
9

Obalon Therapeutics stock price monthly change

-83.54%
month

Obalon Therapeutics stock price quarterly change

-83.54%
quarter

Obalon Therapeutics stock price yearly change

-92.03%
year

Obalon Therapeutics key metrics

Market Cap
 5.47M
Enterprise value
 N/A
P/E
 -2.21
EV/Sales
 -92.41
EV/EBITDA
 1.51
Price/Sales
 265.41
Price/Book
 0.49
PEG ratio
 -0.03
EPS
 -0.81
Revenue
 N/A
EBITDA
 -6.59M
Income
 -7.05M
Revenue Q/Q
 -99.49%
Revenue Y/Y
 -95.83%
Profit margin
 -6501.4%
Oper. margin
 -9908.87%
Gross margin
 60.03%
EBIT margin
 -9908.87%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Obalon Therapeutics stock price history

Obalon Therapeutics stock forecast

Obalon Therapeutics financial statements

Profit Margin

Obalon Therapeutics, Inc. (NASDAQ:OBLN): Profit margin
Sep 2020 44K -1.56M -3545.45%
Dec 2020 61K -1.32M -2172.13%
Mar 2021 0 -4.16M
Jun 2021 3.52K -3.90K -110.57%
OBLN income statement history

Quarterly Earnings

Obalon Therapeutics, Inc. (NASDAQ:OBLN): Earnings per share (EPS)
2020-07-30 -0.3 -0.54
2020-11-06 -0.07 -0.2
2021-03-12 -0.06 -0.17
OBLN earnings history

Debt to Assets

Obalon Therapeutics, Inc. (NASDAQ:OBLN): Debt to assets
Sep 2020 11962000 6.04M 50.49%
Dec 2020 10617000 5.95M 56.06%
Mar 2021 17343000 7.24M 41.77%
Jun 2021 120000000 61.88M 51.57%
OBLN balance sheet history

Cash Flow

Obalon Therapeutics, Inc. (NASDAQ:OBLN): Cash Flow
Sep 2020 -1.29M 0 0
Dec 2020 -1.55M -54K -45K
Mar 2021 -4.44M 0 9.50M
Jun 2021 293K 5.01M 26.82M
OBLN cash flow history

Obalon Therapeutics alternative data

Obalon Therapeutics
Employees

Obalon Therapeutics, Inc. (NASDAQ:OBLN): Employee count
Aug 2023 2
Sep 2023 2
Oct 2023 2
Nov 2023 2
Dec 2023 2
Jan 2024 2
Feb 2024 2
Mar 2024 2
Apr 2024 2
May 2024 2
Jun 2024 2
Jul 2024 2

Obalon Therapeutics other data

Obalon Therapeutics
Insider Trading

Obalon Therapeutics, Inc. (NASDAQ:OBLN): Insider trades (number of shares)
Period Buy Sel
Jun 2021 0 2815145
Aug 2021 30000 0
Sep 2021 0 542860
Transaction Date Insider Security Shares Price per share Total value Source
Sale
STANKOVICH THOMAS officer: Chief Fi.. Common Stock, $0.001 par value per share 48,366 $2.89 $139,778
Sale
GLADNEY DAN W director
 Common Stock, $0.001 par value per share 200,000 $2.99 $598,000
Sale
BANDY BARTON P. director, officer.. Common Stock, $0.001 par value per share 294,494 $2.89 $851,088
Purchase
STANKOVICH THOMAS Common Stock, $0.001 par value per share 15,000 $3.43 $51,435
Purchase
STANKOVICH THOMAS Common Stock, $0.001 par value per share 15,000 $3.22 $48,285
Sale
ARMISTICE CAPITAL, LLC
Common Stock 685,583 $5.48 $3,756,995
Sale
ARMISTICE CAPITAL, LLC
Common Stock 1,106,210 $6.67 $7,372,890
Sale
ARMISTICE CAPITAL, LLC
Common Stock 511,676 $7.65 $3,915,856
Sale
ARMISTICE CAPITAL, LLC
Common Stock 511,676 $7.65 $3,915,856
Purchase
PLOVANIC WILLIAM J. director
 Common Stock 65,000 N/A N/A
OBLN insider trading transactions

Obalon Therapeutics
Patents

Patent
Application
Filling date: 19 May 2021 Issue date: 7 Apr 2022
Application
Filling date: 23 Sep 2019 Issue date: 3 Feb 2022
Application
Filling date: 2 Jul 2021 Issue date: 30 Dec 2021
Application
Filling date: 13 Aug 2020 Issue date: 1 Jul 2021
Grant
Filling date: 24 Aug 2018 Issue date: 29 Dec 2020
Grant
Filling date: 29 May 2018 Issue date: 15 Sep 2020
Grant
Filling date: 24 Oct 2017 Issue date: 15 Sep 2020
Application
Filling date: 1 May 2020 Issue date: 13 Aug 2020
Application
Filling date: 16 Apr 2020 Issue date: 30 Jul 2020
Grant
Filling date: 27 Oct 2017 Issue date: 14 Jul 2020
OBLN patents

Obalon Therapeutics
Earnings Call Transcripts

Quarter Transcript
Q4 2019 29 Feb 2020 Q4 2019 Earnings Call Transcript
Q3 2019 8 Nov 2019 Q3 2019 Earnings Call Transcript
Q2 2019 25 Jul 2019 Q2 2019 Earnings Call Transcript
Q4 2018 22 Feb 2019 Q4 2018 Earnings Call Transcript
OBLN earnings call transcripts

Frequently Asked Questions (FAQ)

  • What's the price of Obalon Therapeutics stock today?

    One share of Obalon Therapeutics stock can currently be purchased for approximately $3.05.

  • When is Obalon Therapeutics's next earnings date?

    Unfortunately, Obalon Therapeutics's (OBLN) next earnings date is currently unknown.

  • Does Obalon Therapeutics pay dividends?

    No, Obalon Therapeutics does not pay dividends.

  • How much money does Obalon Therapeutics make?

    Obalon Therapeutics has a market capitalization of 5.47M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 51.6% to 1.59M US dollars. Obalon Therapeutics made a loss 12.33M US dollars in net income (profit) last year or -$0.17 on an earnings per share basis.

  • What is Obalon Therapeutics's stock symbol?

    Obalon Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "OBLN".

  • What is Obalon Therapeutics's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Obalon Therapeutics?

    Shares of Obalon Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Obalon Therapeutics have?

    As Jul 2024, Obalon Therapeutics employs 2 workers.

  • When Obalon Therapeutics went public?

    Obalon Therapeutics, Inc. is publicly traded company for more then 8 years since IPO on 6 Oct 2016.

  • What is Obalon Therapeutics's official website?

    The official website for Obalon Therapeutics is obalon.com.

  • Where are Obalon Therapeutics's headquarters?

    Obalon Therapeutics is headquartered at 5421 Avenida Encinas Ste F, Carlsbad, CALIFORNIA.

  • How can i contact Obalon Therapeutics?

    Obalon Therapeutics's mailing address is 5421 Avenida Encinas Ste F, Carlsbad, CALIFORNIA and company can be reached via phone at +1 858 480 2400.

Obalon Therapeutics company profile:

Obalon Therapeutics, Inc.

obalon.com
Exchange:

NASDAQ

Full time employees:

2

Industry:

Medical - Devices

Sector:

Healthcare

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.

+1 858 480 2400
5421 Avenida Encinas Ste F
Carlsbad, CALIFORNIA 92008-4410

CIK: 0001427570
ISIN: US67424L2097
CUSIP: 67424L209